CIK 0000894158
- Non-accelerated filer
- Smaller reporting company
Theriva Biologics, Inc.
Sign in to watch- Ticker
- TOVX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 133808303
- Phone
- +1 734-332-7800
- Business address
- 9605 MEDICAL CENTER DRIVE, SUITE 270, ROCKVILLE, MD, 20850
- Former names
- Synthetic Biologics, Inc., ADEONA PHARMACEUTICALS, INC., PIPEX PHARMACEUTICALS, INC., SHEFFIELD PHARMACEUTICALS INC, SHEFFIELD MEDICAL TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2006-10-31 | KANZER STEVE H CEO | Grant or award · Stock Options | +271,058 | 271,058 | ||
| 2006-10-31 | KANZER STEVE H CEO | Purchase | +7,086,379 | 7,086,379 | ||
| 2006-10-31 | KANZER STEVE H CEO | Grant or award · Warrants | +832,606 | 832,606 | ||
| 2006-10-31 | KANZER STEVE H CEO | Grant or award · Stock Options | +271,058 | 271,058 | ||
| 2006-06-30 | MANION MICHAEL F PRES CEO | Grant or award | +436,300 | $0.01 | $4K | 2,766,300 |
| 2006-05-31 | MANION MICHAEL F President | Purchase | +935,000 | $0.01 | $9K | 2,330,000 |
| 2006-05-30 | Bisgaier Charles PhD President | Grant or award · Stock Options | +664,252 | 664,252 | ||
| 2006-01-27 | KANZER STEVE H Chief Executive Officer | Grant or award · Warrants | +3,618,735 | 3,618,735 | ||
| 2006-01-27 | KANZER STEVE H Chief Executive Officer | Grant or award · Warrants | +3,618,735 | 3,618,735 | ||
| 2005-09-30 | MANION MICHAEL F PRESIDENT | Purchase | +1,115,000 | $0.01 | $11K | 1,395,000 |
Page 15 of 15 · 290 trades